HR 4014
107th Congress
House
Health
Agriculture and Food
Authorization
Department of Health and Human Services
Diet
Diseases
Economics and Public Finance
Federal aid to medical research
Government Operations and Politics
Medical supplies
Orphan drugs
Pharmaceutical research
Research grants
Science, Technology, Communications
Rare Diseases Orphan Product Development Act of 2002
Introduced: March 20, 2002
See on congress.gov
Everywhere this bill has been
22 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 6, 2002
Signed by President.
Nov 6, 2002
Became Public Law No: 107-281.
Oct 28, 2002
Presented to President.
Oct 18, 2002
Message on Senate action sent to the House.
Oct 17, 2002
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S10769)
Oct 17, 2002
Passed Senate without amendment by Unanimous Consent. (consideration: CR S10769)
Oct 2, 2002
Received in the Senate, read twice.
Oct 1, 2002
Mr. Shimkus moved to suspend the rules and pass the bill.
Oct 1, 2002
Placed on the Union Calendar, Calendar No. 435.
Oct 1, 2002
Reported by the Committee on Energy and Commerce. H. Rept. 107-702.
Oct 1, 2002
At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Waxman objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was withdrawn.
Oct 1, 2002
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H6815)
Oct 1, 2002
Considered as unfinished business. (consideration: CR H6883)
Oct 1, 2002
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H6815)
Oct 1, 2002
Motion to reconsider laid on the table Agreed to without objection.
Oct 1, 2002
DEBATE - The House proceeded with forty minutes of debate ob H.R. 4014.
Oct 1, 2002
Considered under suspension of the rules. (consideration: CR H6815-6818)
Sep 5, 2002
Ordered to be Reported by Unanimous Consent.
Sep 5, 2002
Committee Consideration and Mark-up Session Held.
Mar 26, 2002
Referred to the Subcommittee on Health.
Mar 20, 2002
Referred to the House Committee on Energy and Commerce.
Mar 20, 2002
Introduced in House
Plain-English summary
Rare Diseases Orphan Product Development Act of 2002 - Amends the Orphan Drug Act to authorize appropriations for FY 2002 through 2006 for grants and contracts for the development of drugs for rare diseases and conditions.
What's happening now
Became Public Law No: 107-281.
Committees of jurisdiction
2